Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Comparator (IDID): Stock Talk Only -- Ignore unavailable to you. Want to Upgrade?

To: Shammymoo who wrote (509)	6/9/1998 3:27:00 AM
From: Dave Gore	Respond to of 610

Just heard about IDID activity. In case you didn;t know, this was a scam stock of big proportions a year or two ago. Featured every day by Joe Kernan on CNBC...for days running. SEC halted trading for several days, weeks? whatever. I made lots of money on it as it ran to about $2.00 but sold just in time..... not bashing exactly....but be careful if you invest... do your DD thoroughly.

To: Shammymoo who wrote (509)	6/9/1998 10:29:00 AM
From: larscot	Read Replies (2) \| Respond to of 610

Shammyoo, at 614M shares outstanding, it will have to have a multi, multi billion dollar year next year to see your $10. I don't think so. But this is a good first step for Comparator in terms of restoring their image, and shows they may have something worth looking at.

To: Shammymoo who wrote (509)	6/12/1998 4:19:00 AM
From: zgoodman	Read Replies (1) \| Respond to of 610

Shammymoo, have a look at KCAP. Key Capital Corp. (OTCBB "KCAP") is a diversified financial management company that wholly-owns or has substantial equity positions in numerous public and private corporations. More like a mini closed-end mutual fund. Sounds pretty dull, huh? Now the exciting part... Their latest success has them providing banking and management services to Crystal Recovery Systems (CRS) - a privately-funded Cancer Research company. KCAP will be coordinating a limited "Seed Share" 504 Offering for CRS, as well as their subsequent Public Listing as an OTC-traded corporation. This may be one of those rare opportunities to "Get In Early" as you say, on one of the many Cancer Development Companies that almost never see the underside of $10.00... Oh yeah, this treatment works on... HUMANS!! Current price: .44 to .50 which is off .10 or so... IR says that there is only about 800K in the float, and to look for increased buying next week. Further details are at the KCAP Web Site: kcap.net Zack (long for KCAP) Goodman